In a recent commentary in the New England Journal of Medicine, Johns Hopkins tobacco policy expert Joanna Cohen and colleagues call for the FDA to take steps to bring more smoking cessation therapies to the market. Cohen, director of the Institute for Global Tobacco Control, talks with Dr. Josh Sharfstein about why new therapies are needed and where to find evidence to support their use. Read the full commentary here: https://www.nejm.org/doi/full/10.1056/NEJMp2301700. If you or someone you know needs help with quitting tobacco products, call 1-800-QUITNOW.
